New York · Seoul · Since 2007
Trendbird
TREND DATABASE (30,000+ Innovations)
 
DAILY TREND REPORT

How Marketers Are Building The Infrastructure For AI Search

Marketers have spent the past year trying to understand how to get their brands mentioned in AI search results. Now, they’re putting dollars and organizing teams around their AI visibility efforts.Key Takeaways82% of consumers say AI-generated content makes it harder to tell what is genuine online, and over half (51%) have already replaced traditional research with AI tools at least once.Nearly two-thirds (65%) of consumers agree that brands overuse the word "authentic" without backing it up, and 76% say marketing today feels more performat...

Heinz’s New Lid Has 3 Settings Based on Your Love Language

Ketchup people are serious people. Not in an uptight way, but in the way that they know exactly what they want: a precise drizzle over scrambled eggs, a controlled zigzag down a hot dog, or the kind of generous pour that basically constitutes a second course. Ketchup rituals are personal, and Heinz, after 157 years of watching people argue silently over the bottle, has finally decided to do something about it.The Heinz Love Lid is a customizable ketchup lid, and yes, that is exactly as delightful as it sounds. It replaces the standard cap on...

Daily Report : 월가를 뒤흔든 25세 AI 천재 레오폴드의 포트폴리오 - 반도체 숏과 AI 인프라 집중 투자

1. 월가를 뒤흔든 25세 AI 천재 레오폴드의 포트폴리오 : 반도체 숏과 AI 인프라 집중 투자 반도체 숏 포지션 및 헤징 전략: Situational Awareness LP가 NVIDIA, AMD, Broadcom, TSMC 등 주요 반도체 기업 및 SMH ETF에 대한 대규모 Put 옵션 포지션을 공시하며 단기 밸류에이션 과열에 대비한 숏 포지션 구축.병목 레이어 대상 Long 포지션 재배치: 반도체 숏 포지션과 달리 CoreWeave, SanDisk 등 AI 클라우드 컴퓨팅 및 메모리/스토리지 병목 레이어 기업의 Long 포지션을 신규 매수하며 선택적 자본 집적 달성.AI 장기 신념과 단기 밸류에이션의 분리: 슈퍼지능에 대한 장기적 신념과...

Ex-OpenAI Star (Leopold Aschenbrenner)'s Fund Holdings Reveleald !

Ex-OpenAI Researcher’s Fund Shorts Major Semis While Doubling Down on Selected AI Infrastructure.Leopold Aschenbrenner, a former OpenAI researcher and founder of Situational Awareness LP, revealed a striking portfolio reallocation in his fund's Q1 2026 filing. Despite being one of the industry's most vocal AI bulls, Aschenbrenner’s fund disclosed substantial put (short) positions against major semiconductor leaders while selectively accumulating long positions in specific AI infrastructure players such as CoreWeave and SanDisk.Bearish / Pu...

MIT Sloan - Who Will Own The AI Agent Economy ?

AI agents are moving from centralized systems toward a decentralized network of trillions of personal and organizational agents.The real business opportunity isn’t building agents for specific tasks — it’s building the marketplaces, protocols, and services that agents will need.A new MIT research initiative called Project NANDA is working to keep the agentic web open before corporate consolidation makes that impossible.MIT’s Ramesh Raskar offers a compelling vision of the future. Suppose a 70-year-old pre-diabetic woman from rural India...

(PDF) Mckinsey - The CEO’s Critical Role In Building New Businesses

Finding organic growth in today's volatile business landscape has become more challenging than ever, prompting global corporate leaders to elevate venture building into a central growth strategy.A July 2026 report published in McKinsey Quarterly, titled The CEO's Critical Role in Building New Businesses, reveals that despite mounting cost pressures and economic uncertainty, approximately 40 percent of global chief executive officers continue to rank new-business building as one of their top three strategic priorities. In fact, when surveyed...

(Paper) So How Is AI Drug Discovery Doing, Really ?

The deluge of articles, presentations, and press releases on the applications of AI techniques to drug discovery does not make it easy to tell just what those applications are and how useful they might be (at least so far). This is an excellent new article from a number of people who know what they’re talking about in the field and who (importantly) are not trying to sell you anything, either.Its authors point out (correctly, I’d say) that the evidence for real clinical impact so far is very thin:“Although a wide variety of AI methods hav...

Running's Boom Goes Premium

Running Is Becoming A Luxury Lifestyle.US running apparel sales climbed 10% to nearly $1B, while sales of $150+ running shoes jumped 46%, per Circana.As run clubs and finisher medals signal identity and status, participation has expanded beyond logging miles — with some runners now spending nearly $1.5K/year on apparel, shoes, gear, race entries, nutrition, and subscriptions.Beyond technical gear, brands like @satisfyrunning, @bandit, and @districtvision built subcultures around taste, community, and belonging. Executing premium playbooks,...

The Risky Business of Experimental Peptides

Surging consumer demand for experimental peptides is outpacing existing safety research and regulatory oversight in the US.Telemedicine firms and clinics are lobbying to legalise distribution pathways, despite warnings that unproven drugs pose health risks.Political pressure to expand access is at odds with the opinion of medical experts.Dr. Anant Vinjamoori was at home enjoying his morning coffee when one of his doctor group chats lit up. A friend had seen something horrifying in Queens: a standard corner bodega, its windows stuffed with ad...
 

About

TRENDBIRD, Inc is a Global Trend Sensing & Market Intelligence Service that Instantly Delivers Industry Expert Information on Emerging Trends & Future Opportunities from Around the World, Ahead of The Curve.
Monthly Trend Report